Drug search by name

Selzentry and Hepatotoxicity/liver impairment

Result of checking the interaction of drug Selzentry and disease Hepatotoxicity/liver impairment for safety when used together.

Check result:

Selzentry <> Hepatotoxicity/liver impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hepatotoxicity has been reported with the use of maraviroc. Symptoms of systemic allergic reaction (pruritic rash, eosinophilia, or elevated Ig E), prior to the development of hepatotoxicity may occur. Patients with signs or symptoms of hepatitis or allergic reaction should be evaluated immediately. Additionally, the safety and efficacy of maraviroc has not been studied in patients with significant underlying liver disorders. Caution should be used when administering maraviroc to patients with preexisting liver dysfunction or who are coinfected with viral hepatitis B or C.

Selzentry

Generic Name: maraviroc

Brand Name: Selzentry

Synonyms: n.a.

What is Selzentry?